Table 1 Patient clinical and pathological variables

From: Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer

 

Number

Valid%

Grade

 1

60

23.3

 2

124

48.2

 3

73

28.4

 Unknown

5

 

Nodal status

 0

128

53.3

 1–3

72

30

 4+

40

16.7

 Unknown

22

 

Histological type

 Ductal

218

83.2

 Lobular

20

7.6

 Other (incl. unknown)

24

9.2

Size (mm)

 T1(<20)

89

36.3

 T2 (20–50)

149

59.1

 T3 (>50)

14

5.6

 Unknown

10

 

NPI

 <3.5

66

35.5

 3.5–5.5

94

50.5

 >5.5

26

14

 Unknown

76

 

Age (years)

 </=50

42

16

 >50

220

84

Chemotherapy

 Yes

68/262

26

 No

194/262

74

Progesterone receptor (PgR) status

 PgR+

165

63

 PgR−

93

35

 PgR unknown

4

1.5

  1. NPI=Nottingham Prognostic Index (grade+nodal status+0.02 × size in mm).
  2. Grade=Bloom and Richardson grade. Nodal status=number of positive nodes, Histological type: ductal, invasive ductal carcinoma; lobular, invasive lobular carcinoma; other includes mucinous, mucoid etc.